DRUG MANAGEMENT OF PATIENT WITH HEART FAILURE AND CARDIAC PACEMAKER

The aim of the study: to consider the management of patients with heart failure (HF) and cardiac pacemaker. HF remains one of the most important problem areas of modern medicine and has a huge social significance due to the widespread, steadily progressing, prognostically unfavorable course and high economic losses. Treatment of HF includes interventions in lifestyle, drug therapy and one of the modern methods is cardiac resynchronization therapy. Pacemakers are well-established therapies of severe bradyarrhythmias, and one of them is complete atrioventricular block.

Our patient: The woman, 78 years old, with complaints of oedema of the shins, cough and dyspnea at minimal exertion, absent at rest. Anamnesis is remarkable significant for arterial hypertension, myocardial infarction (2011, 2014), AV block of IIId degree with Adams-Stokes syndrome. 23.08.17 the cardiac pacemaker was implanted, in the DDDR pacing mode. After implantation of cardiac pacemaker the symptoms were not completely controlled, and patient was hospitalized to the cardiology department to correct the treatment, EF=48%.

Conclusion. Cardiac pacemaker in the presence of possible solutions to the problem of arrhythmias and HF it does not cancel, but modifies the medical support of patients. To prolong patient’s life, it’s very important to establish a timely diagnosis and prescribean appropriate therapy.